|
US2021030655A1
|
|
Cosmetic compositions to prevent and/or ameliorate skin aging and methods of applications
|
|
PH12014000105A1
|
|
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
|
|
PH12014000104A1
|
|
Therapeutic methods and compositions for treating diabetes
|
|
BR102014006730A2
|
|
Therapeutic methods and compositions for treating diabetes
|
|
US2015265644A1
|
|
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
|
|
SG10201400823PA
|
|
Therapeutic methods and compositions for treating diabetes
|
|
KR20150109773A
|
|
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
|
|
SG10201400824YA
|
|
Therapeutic Methods And Compositions For Treating Diabetes Utilizing Diterpenoid Compounds
|
|
AU2014201695A1
|
|
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
|
|
US2015265682A1
|
|
Therapeutic methods and compositions for treating diabetes
|
|
KR20150109774A
|
|
Therapeutic methods and compositions for treating diabetes
|
|
CA2847286A1
|
|
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
|
|
AU2014201696A1
|
|
Therapeutic methods and compositions for treating diabetes
|
|
CA2847250A1
|
|
Therapeutic methods and compositions for treating diabetes
|
|
BR102014006729A2
|
|
Therapeutic methods and compositions for treating diabetes using diterpenoid compounds
|
|
TW200704410A
|
|
Controlled release medicinal composition of sleeping drug and method for producing the same
|
|
EP1711146A1
|
|
Transdermal delivery of oxybutynin in gel formulations
|
|
TW200512013A
|
|
Gel formulation of oxybutynin hydrochloride
|
|
TW200427414A
|
|
Method for producing nutritional product containing L-Arginine
|
